Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 1, 2000

View Archived Issues

Italian Firm Novuspharma Seeks EUR177.3M In Combined Offering

Amrad Cutting Back Operations To Focus On Research Portfolio

European Scientists To Convene On Use Of Genomic Information

Fallout From Cantab Setback Continues With CEO Departure

European Commission Prepares Criteria For GMM Contained Use

Astex Signs Deal With Janssen, Plans Second Funding Round

CAT, HGS Extend Collaboration To Develop Antibodies For BLyS

Industry Seeks Change Of Focus From National To European Level

Jump In Genset's Quarterly Loss Linked To New Corporate Strategy

Medarex Increases IDM Stake Through Licensing Agreement

Uroghne Enters Research Deal, Closes Its First Funding Round

MediGene and Schering Move Cancer Vaccine Into Phase I/II

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...